June 22, 2024Open Access

Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT

Key Points

Key points are not available for this paper at this time.

Abstract

To evaluate the cardiovascular effects of semaglutide by baseline glycated hemoglobin (HbA1c) and change in HbA1c in a prespecified analysis of Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT).

Read Full Paperexternally

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Journals

Diabetes Care

Institutions

Harvard University

University of Washington

Centre National de la Recherche Scientifique

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.